Corrigendum: SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia
about
Corrigendum: SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia
description
article
@en
im Juni 2017 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 2017
@uk
name
Corrigendum: SAMHD1 is a bioma ...... rget in acute myeloid leukemia
@en
Corrigendum: SAMHD1 is a bioma ...... rget in acute myeloid leukemia
@nl
type
label
Corrigendum: SAMHD1 is a bioma ...... rget in acute myeloid leukemia
@en
Corrigendum: SAMHD1 is a bioma ...... rget in acute myeloid leukemia
@nl
prefLabel
Corrigendum: SAMHD1 is a bioma ...... rget in acute myeloid leukemia
@en
Corrigendum: SAMHD1 is a bioma ...... rget in acute myeloid leukemia
@nl
P2093
P50
P921
P356
P1433
P1476
Corrigendum: SAMHD1 is a bioma ...... rget in acute myeloid leukemia
@en
P2093
Alexander F Yakunin
Anjali Cremer
Christoph Schliemann
Constanze Schneider
Dominique Thomas
Eva Wardelmann
Federico Comoglio
Gerd Geisslinger
Hanibal Bohnenberger
Hanna-Mari Baldauf
P2888
P356
10.1038/NM0617-788A
P407
P577
2017-06-01T00:00:00Z